Amelioration of cyclosporin A effect on microvasculature by endothelin inhibitor

Surgery

Volumn 134, Issue 2, 2003, Pages 384-389

  Wilasrusmee, Chumpon ^b   Ondocin, Phil ^b   Bruch, David ^b   Shah, Gaurang ^b   Kittur, Smita ^b   Wilasrusmee, Skuntala ^b   Kittur, Dilip S ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOSPORIN A; ENDOTHELIN 1; ENDOTHELIN 1 ANTIBODY; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; MATRIGEL; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM LESION; FISHER EXACT TEST; KAPLAN MEIER METHOD; MICROVASCULATURE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN; SURVIVAL;

EID: 0042829134     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.233     Document Type: Article

References (18)

1. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002;73:775-82.
2. Ovuworie CA, Fox ER, Chow CM, Pascual M, Shih VE, Picard MH, et al. Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. Transplantation 2001;72:1385-8.
3. First MR. Strategies to minimize immunological and non-immunological risk factors in the renal transplant population. Transplantation 2001;72(6 Suppl):S20-4.
4. Ribatti D, Vacca A, Cantatore FP, Ria R, Benagiano V, Roncali L, et al. An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis. Inflamm Res 2000;49:418-23.
5. Iurlaro M, Vacca A, Minischetti M, Ribatti D, Pellegrino A, Sardanelli A, et al. Antiangiogenesis by cyclosporine. Exp Hematol 1998;26:1215-22.
6. Norrby K. Cyclosporine is angiostatic. Experientia 1992;48 (11-12):1135-8.
7. Wilasrusmee C, Da Silva M, Singh B, Kittur S, Siddiqui J, Bruch D, et al. A new in vitro model to study endothelial injury. J Surg Res 2002;104:131-6.
8. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001;12:1448-57.
9. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-I. J Am Soc Nephrol 2001;12:1434-47.
10. Moulton KS, Melder RJ, Dharnidharka VR, Hardin-Young J, Jain RK, Briscoe DM. Angiogenesis in the huPBL-SCID model of human transplant rejection. Transplantation 1999;67:1626-31.
11. Conant AR, Oo AY, Dashwood MR, Collard K, Chester MR, Dihmis WC, et al. Endothelin receptors in cultured and native human radial artery smooth muscle. J Cardiovasc Pharmacol 2002;39:130-41.
12. Sanchez R, MacKenzie A, Farhat N, Nguyen TD, Stewart DJ, Mercier I, et al. Endothelin B receptor-mediated regulation of endothelin-1 content and release in cultured porcine aorta endothelial cell. J Cardiovasc Pharmacol 2002;39:652-9.
13. Ergul A. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy 2002;22:54-65.
14. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995;170:39-49.
15. Wilasrusmee C, Da Silva M, Singh B, Kittur S, Siddiqui J, Bruch D, et al. A new in vitro model to study endothelial injury. J Surg Res 2002;104:131-6.
16. Samuels BL, Mick R, Vogelzang NJ, Williams SF, Schilsky RL, Safa AR, et al. Modulation of vinblastine resistance with cyclosporine: a phase I study. Clin Pharmacol Ther 1993;54:421-9.
17. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994;89:1573-79.
18. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-55.